A detailed history of Cibc Asset Management Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 15,938 shares of TXG stock, worth $257,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,938
Previous 95,259 83.27%
Holding current value
$257,717
Previous $1.85 Million 80.62%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$15.71 - $23.49 $1.25 Million - $1.86 Million
-79,321 Reduced 83.27%
15,938 $359,000
Q2 2024

Aug 01, 2024

BUY
$19.45 - $37.37 $449,528 - $863,695
23,112 Added 32.03%
95,259 $1.85 Million
Q1 2024

May 09, 2024

BUY
$36.08 - $54.3 $2.6 Million - $3.92 Million
72,147 New
72,147 $2.71 Million
Q1 2023

May 12, 2023

SELL
$35.33 - $55.79 $4.54 Million - $7.16 Million
-128,394 Reduced 44.4%
160,750 $8.97 Million
Q4 2022

Feb 13, 2023

SELL
$24.4 - $41.3 $1.13 Million - $1.91 Million
-46,262 Reduced 13.79%
289,144 $10.5 Million
Q3 2022

Nov 03, 2022

BUY
$28.48 - $52.59 $9.55 Million - $17.6 Million
335,406 New
335,406 $9.55 Million
Q2 2022

Aug 09, 2022

SELL
$36.95 - $82.41 $167,383 - $373,317
-4,530 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$135.05 - $182.59 $15,395 - $20,815
114 Added 2.58%
4,530 $675,000
Q3 2021

Nov 09, 2021

BUY
$145.58 - $192.14 $64,200 - $84,733
441 Added 11.09%
4,416 $643,000
Q1 2021

May 14, 2021

BUY
$140.25 - $196.86 $64,935 - $91,146
463 Added 13.18%
3,975 $719,000
Q3 2020

Nov 05, 2020

BUY
$87.44 - $125.0 $7,607 - $10,875
87 Added 2.54%
3,512 $438,000
Q4 2019

Feb 14, 2020

BUY
$46.07 - $79.54 $157,789 - $272,424
3,425 New
3,425 $261,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.